Silo Pharma, Inc.
SILO
$6.12
$0.315.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Cost of Revenue | 63.60K | 44.40K | 25.20K | 6.00K | 6.00K |
| Gross Profit | 8.50K | 27.80K | 47.10K | 66.40K | 66.40K |
| SG&A Expenses | 2.21M | 2.15M | 2.42M | 2.33M | 2.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.85M | 4.35M | 5.38M | 5.24M | 4.99M |
| Operating Income | -4.78M | -4.28M | -5.31M | -5.17M | -4.92M |
| Income Before Tax | -4.84M | -4.23M | -5.08M | -4.90M | -4.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.84 | -4.23 | -5.08 | -4.90 | -4.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.84M | -4.23M | -5.08M | -4.90M | -4.62M |
| EBIT | -4.78M | -4.28M | -5.31M | -5.17M | -4.92M |
| EBITDA | -4.77M | -4.27M | -5.30M | -5.16M | -3.91M |
| EPS Basic | -7.45 | -9.10 | -13.89 | -15.35 | -17.05 |
| Normalized Basic EPS | -4.66 | -5.69 | -8.69 | -9.60 | -10.66 |
| EPS Diluted | -7.45 | -9.10 | -13.89 | -15.35 | -17.05 |
| Normalized Diluted EPS | -4.66 | -5.69 | -8.69 | -9.60 | -10.66 |
| Average Basic Shares Outstanding | 2.85M | 2.23M | 1.64M | 1.30M | 1.09M |
| Average Diluted Shares Outstanding | 2.85M | 2.23M | 1.64M | 1.30M | 1.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |